BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and other solid cancers, tumor-stroma reaction (TSR) is long observed by pathologists and has been found correlated with patient prognosis. However, paucity of study aims to overcome subjective bias or automate TSR evaluation for enabling association analysis to a large cohort.Materials and methodsServing as positive and negative sets of TSR studies, H&E slides of primary tumors of high-grade serous ovarian carcinoma (HGSOC) (n = 291) and serous borderline ovarian tumor (SBOT) (n = 15) were digitally scanned. Three pathologist-defined quantification criteria were used to characterize the extents of TSR. Scores for each criterion were annotated (0/1/...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...
Contains fulltext : 204300.pdf (publisher's version ) (Open Access)PURPOSE: Tumor-...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
Background: The development of a reactive tumour stroma is a hallmark of tumour progression and pron...
A For three different Pearson’s correlation p value thresholds (10–2,10–4, 10–6, respectively, from ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background: The development of a reactive tumour stroma is a hallmark of tumour progression and pron...
Although stromal cell signaling has been shown to play a significant role in the progression of many...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...
Contains fulltext : 204300.pdf (publisher's version ) (Open Access)PURPOSE: Tumor-...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
BackgroundAs one of the key criteria to differentiate benign vs. malignant tumors in ovarian and oth...
Background: The development of a reactive tumour stroma is a hallmark of tumour progression and pron...
A For three different Pearson’s correlation p value thresholds (10–2,10–4, 10–6, respectively, from ...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Background: The development of a reactive tumour stroma is a hallmark of tumour progression and pron...
Although stromal cell signaling has been shown to play a significant role in the progression of many...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...
Contains fulltext : 204300.pdf (publisher's version ) (Open Access)PURPOSE: Tumor-...
BackgroundOvarian cancer (OC) is a highly heterogeneous and malignant gynecological cancer, thereby ...